Quote from email:
	The greatest limitation is EDUCATION. These tests would be
considered high complexity, requiring the CLIA mandated education level of
those doing this screening and this in effect would eliminate many
histotechs.


These tests are ALREADY considered high complexity and mandated by CLIA.
And under CLIA, it's the pathologist (not the histologist) who is ultimately
responsible for ALL histology testing.     


On a more personal issue, having a Her2 positive breast cancer, I am not
comfortable with a tech making this diagnosis.
Nor would I be comfortable making this decision for a patient.
Herceptin is a VERY expensive  ($1200) weekly treatment and I will probably
take it until I die.   (unless I develop heart problems from the herceptin
itself)     This test (and ER/PR)  determines serious decisions in therapy
for a breast cancer patient.

Maybe I am too personally involved with this thread to be subjective.   

Hazel Horn, HT/HTL